Lysosomal diseases: Overview on current diagnosis and treatment

Fabianodeoliveira Poswar, Filippo Vairo, Maira Burin, Kristiane Michelin-Tirelli, Anacarolina Brusius-Facchin, Francyne Kubaski, Carolinafischingermoura Desouza, Guilherme Baldo, Roberto Giugliani

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Lysosomal diseases (LDs), also known as lysosomal storage diseases (LSDs), are a heterogeneous group of conditions caused by defects in lysosomal function. LDs may result from deficiency of lysosomal hydrolases, membrane- associated transporters or other non-enzymatic proteins. Interest in the LD field is growing each year, as more conditions are, or will soon be treatable. In this article, we review the diagnosis of LDs, from clinical suspicion and screening tests to the identification of enzyme or protein deficiencies and molecular genetic diagnosis. We also cover the treatment approaches that are currently available or in development, including hematopoietic stem cell transplantation, enzyme replacement therapy, small molecules, and gene therapy.

Original languageEnglish (US)
Pages (from-to)165-177
Number of pages13
JournalGenetics and Molecular Biology
Volume42
Issue number1
DOIs
StatePublished - 2019

Keywords

  • Enzyme replacement therapy
  • Gene therapy
  • Hematopoietic stem cell transplantation
  • Lysosomal storage diseases
  • Neonatal screening

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Fingerprint Dive into the research topics of 'Lysosomal diseases: Overview on current diagnosis and treatment'. Together they form a unique fingerprint.

  • Cite this

    Poswar, F., Vairo, F., Burin, M., Michelin-Tirelli, K., Brusius-Facchin, A., Kubaski, F., Desouza, C., Baldo, G., & Giugliani, R. (2019). Lysosomal diseases: Overview on current diagnosis and treatment. Genetics and Molecular Biology, 42(1), 165-177. https://doi.org/10.1590/1678-4685-gmb-2018-0159